JP2017531425A5 - - Google Patents

Download PDF

Info

Publication number
JP2017531425A5
JP2017531425A5 JP2017516783A JP2017516783A JP2017531425A5 JP 2017531425 A5 JP2017531425 A5 JP 2017531425A5 JP 2017516783 A JP2017516783 A JP 2017516783A JP 2017516783 A JP2017516783 A JP 2017516783A JP 2017531425 A5 JP2017531425 A5 JP 2017531425A5
Authority
JP
Japan
Prior art keywords
stem cells
mesenchymal stem
population
induction medium
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017516783A
Other languages
English (en)
Japanese (ja)
Other versions
JP6890538B2 (ja
JP2017531425A (ja
Filing date
Publication date
Priority claimed from US14/504,399 external-priority patent/US20160095885A1/en
Application filed filed Critical
Publication of JP2017531425A publication Critical patent/JP2017531425A/ja
Publication of JP2017531425A5 publication Critical patent/JP2017531425A5/ja
Priority to JP2021068586A priority Critical patent/JP7672867B2/ja
Application granted granted Critical
Publication of JP6890538B2 publication Critical patent/JP6890538B2/ja
Priority to JP2023077664A priority patent/JP7773502B2/ja
Priority to JP2025091622A priority patent/JP2025131663A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017516783A 2014-10-01 2015-09-24 幹細胞培養および療法のための誘導培地および方法 Active JP6890538B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2021068586A JP7672867B2 (ja) 2014-10-01 2021-04-14 幹細胞培養および療法のための誘導培地および方法
JP2023077664A JP7773502B2 (ja) 2014-10-01 2023-05-10 幹細胞培養および療法のための誘導培地および方法
JP2025091622A JP2025131663A (ja) 2014-10-01 2025-06-02 幹細胞培養および療法のための誘導培地および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/504,399 2014-10-01
US14/504,399 US20160095885A1 (en) 2014-10-01 2014-10-01 Induction Medium & Methods for Stem Cell Culture & Therapy
PCT/US2015/052029 WO2016053758A1 (en) 2014-10-01 2015-09-24 Induction medium and methods for stem cell culture and therapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021068586A Division JP7672867B2 (ja) 2014-10-01 2021-04-14 幹細胞培養および療法のための誘導培地および方法

Publications (3)

Publication Number Publication Date
JP2017531425A JP2017531425A (ja) 2017-10-26
JP2017531425A5 true JP2017531425A5 (Direct) 2018-11-08
JP6890538B2 JP6890538B2 (ja) 2021-06-18

Family

ID=55631287

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2017516783A Active JP6890538B2 (ja) 2014-10-01 2015-09-24 幹細胞培養および療法のための誘導培地および方法
JP2021068586A Active JP7672867B2 (ja) 2014-10-01 2021-04-14 幹細胞培養および療法のための誘導培地および方法
JP2023077664A Active JP7773502B2 (ja) 2014-10-01 2023-05-10 幹細胞培養および療法のための誘導培地および方法
JP2025091622A Pending JP2025131663A (ja) 2014-10-01 2025-06-02 幹細胞培養および療法のための誘導培地および方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021068586A Active JP7672867B2 (ja) 2014-10-01 2021-04-14 幹細胞培養および療法のための誘導培地および方法
JP2023077664A Active JP7773502B2 (ja) 2014-10-01 2023-05-10 幹細胞培養および療法のための誘導培地および方法
JP2025091622A Pending JP2025131663A (ja) 2014-10-01 2025-06-02 幹細胞培養および療法のための誘導培地および方法

Country Status (11)

Country Link
US (6) US20160095885A1 (Direct)
EP (2) EP4234032A3 (Direct)
JP (4) JP6890538B2 (Direct)
KR (10) KR102636786B1 (Direct)
CN (1) CN107002029A (Direct)
AU (4) AU2015324241B2 (Direct)
CA (2) CA3210154A1 (Direct)
ES (1) ES2961691T3 (Direct)
MX (1) MX2017004288A (Direct)
RU (1) RU2717983C2 (Direct)
WO (1) WO2016053758A1 (Direct)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160095885A1 (en) 2014-10-01 2016-04-07 WibiWorks Therapeutics, Inc. Induction Medium & Methods for Stem Cell Culture & Therapy
SG11201804220SA (en) 2015-12-07 2018-06-28 Univ Colorado State Res Found Activated stem cells and systemic treatment methods for infected wounds
KR102293012B1 (ko) * 2016-03-31 2021-08-27 샌바이오, 인크. 줄기 세포 배양 및 치료를 위한 배지, 방법, 세포 및 분비 인자
WO2018067925A1 (en) * 2016-10-06 2018-04-12 Transgenex Nanobiotech, Inc. Methods for cancer stem cell (csc) expansion
EP3532606A4 (en) * 2016-10-27 2020-07-29 The Trustees of Columbia University in the City of New York IMMUNOSUPPRESSIVE MESENCHYMA CELLS AND THEIR METHODS OF FORMATION
EP3560527B1 (en) * 2016-12-16 2024-01-31 Regene Pharm Co., Ltd. Tissue healing agent
CA3140452A1 (en) * 2018-06-11 2019-12-19 Angelita De Francisco Extracellular vesicles derived from mesenchymal stem cells
JP7430914B2 (ja) * 2018-08-29 2024-02-14 株式会社Regene Pharm がんの治療のための医薬組成物
CN113271983A (zh) 2018-10-30 2021-08-17 生命剂量公司 治疗性的哺乳动物细胞的口服递送
EP3994245A1 (en) * 2019-07-05 2022-05-11 Case Western Reserve University Priming media and methods for stem cell culture and therapy
KR20230038776A (ko) * 2020-07-16 2023-03-21 상하이 지아오통 유니버시티 중간엽 줄기세포에 의한 케모카인 및 사이토카인의 표적 수송을 위한 면역 요법
KR102460408B1 (ko) * 2020-07-23 2022-10-28 포항공과대학교 산학협력단 줄기세포 시트를 제조하는 방법
TWI888659B (zh) * 2021-10-13 2025-07-01 芯芮生技開發股份有限公司 幹細胞條件培養基於製備抑制癌症組成物的用途
KR20250076941A (ko) * 2023-11-23 2025-05-30 (주) 넥셀 인간 전분화능 줄기세포 유래 심장 오가노이드를 이용해 허혈-재관류 손상에 의해 성체 급성 심근경색 및 심부전 질환이 유도된 체외 질환 모사 모델 제조 방법 및 이를 통해 제조된 체외 질환 모사 모델

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855510B2 (en) * 2001-03-20 2005-02-15 Dana Farber Cancer Institute, Inc. Pharmaceuticals and methods for treating hypoxia and screening methods therefor
EP2298862B1 (en) 2004-03-22 2017-08-30 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
EP1756267A2 (en) 2004-05-14 2007-02-28 Becton, Dickinson and Company Stem cell populations and methods of use
WO2007136673A2 (en) 2006-05-19 2007-11-29 Medistem Laboratories, Inc. Treatment of disc degenerative disease and compositions for same
US20110044958A1 (en) 2008-03-14 2011-02-24 The Board Of Trustees Of The University Of Illinois Activated mesenchymal stem cells for the prevention and repair of inflammatory states
ES2729557T3 (es) 2008-05-28 2019-11-04 Univ Ramot Células madre mesenquimatosas para el tratamiento de enfermedades del SNC
CN101407790B (zh) * 2008-10-30 2010-09-29 浙江大学 一种增强人骨髓间充质干细胞旁分泌能力的处理方法
WO2011068792A2 (en) * 2009-12-01 2011-06-09 The Regents Of The University Of California Compositions and methods for making and using bone marrow mesenchymal stem cells and erythroid progenitor cells
US20140017787A1 (en) 2010-10-11 2014-01-16 Aline M. Betancourt Mesenchymal stem cells and related therapies
CN106692193B (zh) 2011-04-06 2021-01-05 桑比欧公司 用于调节外周免疫功能的方法和组合物
WO2012150707A1 (ja) 2011-05-02 2012-11-08 国立大学法人熊本大学 幹細胞からインスリン産生細胞への分化誘導を促進する低分子化合物および該化合物を用いた幹細胞からインスリン産生細胞への分化誘導方法
AU2012345630A1 (en) * 2011-11-30 2014-07-17 Astellas Institute For Regenerative Medicine Mesenchymal stromal cells and uses related thereto
CA2876512C (en) * 2012-07-11 2022-12-13 Imstem Biotechnology, Inc. Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
US20160095885A1 (en) 2014-10-01 2016-04-07 WibiWorks Therapeutics, Inc. Induction Medium & Methods for Stem Cell Culture & Therapy
CN104845933A (zh) * 2015-05-15 2015-08-19 大连理工大学 一种增强脂肪间充质干细胞免疫学性能和迁移能力的方法
KR102293012B1 (ko) 2016-03-31 2021-08-27 샌바이오, 인크. 줄기 세포 배양 및 치료를 위한 배지, 방법, 세포 및 분비 인자

Similar Documents

Publication Publication Date Title
JP2017531425A5 (Direct)
Ferrari et al. Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking
Antoniou et al. Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression
AU2020223733B2 (en) Compositions and methods for the treatment of hemoglobinopathies
AU2013290146B2 (en) Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
CN108064280B (zh) 利用以凝血因子viii基因为靶的核酸内切酶的a型血友病治疗用组合物
Reavie et al. Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase–substrate complex
Tsuji et al. Secretomes from mesenchymal stem cells against acute kidney injury: possible heterogeneity
JP2021182934A (ja) アルファ1アンチトリプシン欠乏症の治療のための材料および方法
US20210161967A1 (en) Extracellular vesicles and uses thereof
US20240360414A1 (en) Systems and Methods for Base Editing Of HBG1/2 Gene Promoter and Fetal Hemoglobin Induction
CN114174493A (zh) 使用带电表面从诱导多能干细胞产生多个谱系的方法
ES2908553T3 (es) Métodos para expandir una población de macrófagos alveolares en un cultivo de larga duración
WO2021026294A1 (en) Methods and compositions for reconstituting microglia
Choi et al. Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington’s disease
US20200354741A1 (en) Gene-editing systems for modifying a scn9a or scn10a gene and methods of use thereof
EP3773637A1 (en) Methods for treating sickle cell disease
Fontana et al. Multiplex base editing of BCL11A regulatory elements to treat sickle cell disease
US20240269189A1 (en) Extracellular vesicle-enriched secretome composition derived from induced pluripotent stem cell derived-microglia and methods of use thereof
WO2019111198A1 (en) Extracellular vesicles and uses thereof
WO2023239609A1 (en) Promoting nutrient absorption through the colon
CN114990164A (zh) 中介体复合物亚基抑制剂及其应用
US20230392145A1 (en) Promoting nutrient absorption through the colon
Brito Minicircle production and delivery to human mesenchymal stem/stromal cells for angiogenesis stimulation
WO2024015933A2 (en) Transplanting stem cell-derived microglia to treat leukodystrophies